0      0

29th Napa Pain Conference Posters

A Prospective Multi-Center Study Of A Differential Target Multiplexed TM Stimulation Derivative In Therapy Naive Patients

Aug 19, 2022 12:00am ‐ Aug 19, 2022 12:00am


Differential Target MultiplexedTM spinal cord stimulation (SCS) is an established therapy that has shown superior back pain relief to traditional SCS.1 This study evaluates efficacy, device longevity, and recharge requirements of a reduced DTMTM derivative in patients with severe back and leg pain to understand opportunities to tailor therapy based on patient profiles and estimate device longevity and recharge requirements. Subjects were trialed with the DTMTM derivative and those who reported ≥50% improvement in overall pain were eligible for implant. Implanted subjects have reported therapy satisfaction and improved quality of life through 3-months and sustained overall pain relief through 6-months.


You must be logged in and own this session in order to post comments.